{"url_path":"/sec/rani/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1856725/0001193125-26-226703-index.html","accession_number":"0001193125-26-226703","cik":"0001856725","ticker":"RANI","issuer_name":"Rani Therapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1856725/0001193125-26-226703-index.html","primary_entity_key":"0001856725","primary_entity_name":"Rani Therapeutics Holdings, Inc."},"word_count":72,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nFrom time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors."}